NTE Trademark

Trademark Overview

On Tuesday, September 18, 2012, a trademark application was filed for NTE with the United States Patent and Trademark Office. The USPTO has given the NTE trademark a serial number of 85731674. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 19, 2021. This trademark is owned by TEVA Pharmaceutical Industries Limited. The NTE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Custom design and development of supergeneric pharmaceutical preparations to address specific patient needs
nte

General Information

Serial Number85731674
Word MarkNTE
Filing DateTuesday, September 18, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 19, 2021
Registration Number4568937
Registration DateTuesday, July 15, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 12, 2013

Trademark Statements

Goods and ServicesCustom design and development of supergeneric pharmaceutical preparations to address specific patient needs

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 19, 2021
Primary Code042
First Use Anywhere DateWednesday, December 4, 2013
First Use In Commerce DateWednesday, December 4, 2013

Trademark Owner History

Party NameTEVA Pharmaceutical Industries Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressJerusalem 91010
IL
Party NameTEVA Pharmaceutical Industries Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJerusalem 91010
IL
Party NameTEVA Pharmaceutical Industries Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJerusalem 91010
IL

Trademark Events

Event DateEvent Description
Friday, February 19, 2021CANCELLED SEC. 8 (6-YR)
Monday, July 15, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, June 1, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 1, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 15, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, June 10, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 3, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 12, 2014STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 22, 2014USE AMENDMENT FILED
Tuesday, April 22, 2014TEAS STATEMENT OF USE RECEIVED
Tuesday, April 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 4, 2014EXTENSION 2 GRANTED
Friday, April 4, 2014EXTENSION 2 FILED
Friday, April 4, 2014TEAS EXTENSION RECEIVED
Wednesday, November 13, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 12, 2013EXTENSION 1 GRANTED
Wednesday, October 2, 2013EXTENSION 1 FILED
Thursday, November 7, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 2, 2013TEAS EXTENSION RECEIVED
Tuesday, April 9, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 12, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 12, 2013PUBLISHED FOR OPPOSITION
Wednesday, January 23, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 28, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 28, 2012ASSIGNED TO EXAMINER
Friday, September 21, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 21, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

address specific patient needs preparations pharmaceutical design development supergeneric custom